Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| DICLOFENAC SODIUM | ANNUVA 50 mg Tablet | 50 | 17.65 | Details | |
| QUETIAPINE | SERCAND 25 mg film-coated tablet | 25 | 19.95 | Details | |
| MOMETASONE FUROATE | MASTASONE 0.05% NASAL SPRAY | 0.05 | 22.65 | Details | |
| ALENDRONATE SODIUM | BINOSTO 70 mg EFFERVESCENT TABLET | 70 | 28.5 | Details | |
| THIAMINE,PYRIDOXINE,CYANOCOBALAMIN | NEUROBION ampoules | 100,100,1000 | 45.5 | Details | |
| DESLORATADINE | DESLORATADINE/GENEPHARM 5 mg film-coated tablet | 5 | 16.75 | Details | |
| MONTELUKAST SODIUM | MONCAS 5 mg Chewable Tablet | 5 | 40.05 | Details | |
| TIOTROPIUM,OLODATEROL | SPIOLTO RESPIMATE | 2.5,2.5 | 200.05 | Details | |
| PROPOFOL | PROPOFOL-LIPURO 0.5% EMULSION FOR Inj./Infusion | 0.5 | 62.25 | Details | |
| USTEKINUMAB | STELARA 130MG/26ML Concentrate for solution for infusion | 130 | 8020.20 | Details | |
| AVANAFIL | SPEDRA 50 mg Tablet | 50 | 54.50 | Details | |
| PANTOPRAZOLE | PANLOCK 40 mg Enteric coated tablet | 40 | 18.8 | Details | |
| AVANAFIL | SPEDRA 100 mg Tablet | 100 | 59 | Details | |
| ALIROCUMAB | PRALUENT 150 mg Prefilled Pen | 150 | 936.55 | Details | |
| ALIROCUMAB | PRALUENT 75 mg Prefilled Pen | 75 | 936.55 | Details | |
| ALOGLIPTIN BENZOATE, PIOGLITAZONE | INCRESYNC 25/15 mg Tablet | 25, 15 | 137.6 | Details | |
| ALOGLIPTIN BENZOATE, PIOGLITAZONE | INCRESYNC 25/30 mg Tablet | 25, 30 | 159.75 | Details | |
| ALOGLIPTIN BENZOATE, PIOGLITAZONE | INCRESYNC 25/45 mg Tablet | 25, 45 | 175.75 | Details | |
| ETHINYLESTRADIOL,GESTODENE | LINDYNETTE 0.075/0.03 mg Film-coated Tablet | 0.03,0.075 | 18.4 | Details | |
| ETHINYLESTRADIOL, GESTODENE | LINDYNETTE 0.075/0.03 mg Film-coated Tablet | 0.03, 0.075 | 55.2 | Details |
7.14% of users said yes from 112 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.